Orforglipron clinical trials: 31 trials
Page 1 of 1
Read 31 Orforglipron clinical trials with posted results or linked papers with results in PepBank.
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT05869903 · Phase 3 · Active, not recruiting
Posted results
- A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
NCT06045221 · Phase 3 · Completed
Posted results
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
NCT05872620 · Phase 3 · Completed
Posted results
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
NCT05971940 · Phase 3 · Completed
Posted results
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
NCT06109311 · Phase 3 · Completed
Posted results
- A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
NCT06010004 · Phase 3 · Completed
Posted results
- A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
NCT05931380 · Phase 3 · Completed
Posted results
- A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
NCT05803421 · Phase 3 · Completed
Linked paper with results
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
NCT06192108 · Phase 3 · Completed
Linked paper with results
- A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
NCT06584916 · Phase 3 · Completed
Linked paper with results
- A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
NCT05048719 · Phase 2 · Completed
Posted results
- A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
NCT05051579 · Phase 2 · Completed
Posted results
- A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
NCT06440980 · Phase 1 · Completed
Posted results
- A Study of LY3502970 in Healthy Participants
NCT03929744 · Phase 1 · Completed
Posted results
- A Study of LY3502970 in Healthy Overweight and Obese Participants
NCT05313802 · Phase 1 · Completed
Posted results
- A Study of LY3502970 in Participants With Type 2 Diabetes
NCT04426474 · Phase 1 · Completed
Posted results
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
NCT05086445 · Phase 1 · Completed
Posted results
- A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
NCT05841238 · Phase 1 · Completed
Posted results
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
NCT06186622 · Phase 1 · Completed
Posted results
- A Study of Two Different Formulations of LY3502970 in Healthy Participants
NCT05341089 · Phase 1 · Completed
Posted results
- A Multiple-Dose Study of LY3502970 in Healthy Participants
NCT05110794 · Phase 1 · Completed
Posted results
- A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
NCT05573230 · Phase 1 · Completed
Posted results
- A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
NCT06370728 · Phase 1 · Completed
Posted results
- A Study of LY3502970 in Participants With Impaired and Normal Liver Function
NCT05882032 · Phase 1 · Completed
Posted results
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
NCT06704763 · Phase 1 · Completed
Posted results
- A Multiple Dose Study of LY3502970 in Healthy Participants
NCT05051566 · Phase 1 · Completed
Posted results
- A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
NCT05469126 · Phase 1 · Completed
Posted results
- A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
NCT06023095 · Phase 1 · Completed
Posted results
- A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
NCT05936138 · Phase 1 · Completed
Posted results
- A Phase I Study of LY3502970 in Healthy Participants
NCT06085482 · Phase 1 · Completed
Posted results
- A Study of LY3502970 in Healthy Male Participants
NCT04680767 · Phase 1 · Completed
Posted results